BIODERMIS
Live / Registered — Registered and renewed (as of 13 May 2020)
What this means for you
Registered since 24 Aug 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Aug 2020).
Record
- Serial number
- 76409086
- Registration number
- 3836414
- Mark type
- Word mark
- Filed
- 17 May 2002
- Published for opposition
- 08 Jun 2010
- Registered
- 24 Aug 2010
- Next maintenance due
- 24 Aug 2020
- Attorney of record
- R. Lee Fraley
Goods and services
- Class 005 — Pharmaceuticals: Topical gel for medical and therapeutic use for the treatment of scars
Owner
- BIODERMIS CORPORATION, HENDERSON, NV, US
- BIODERMIS CORPORATION, HENDERSON, NV, US
- NV BIOMEDICAL, INC., Henderson, NV, US
- NV BIOMEDICAL, INC., Henderson, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
- HPL Biomedical, Inc., Las Vegas, NV, US
Prosecution history
- 04 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Dec 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 07 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Sept 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 27 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 May 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 May 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 May 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED